The Next Generation Diabetes Drugs

The primary goal of Glucox Biotech is to develop a clinically applicable therapeutic drug for treatment of type 2 diabetes and insulin resistance.


The highly favourable benefits of Glucox Biotech’ therapy is to decrease the critical risks and delay progression of the complications in Type 2 Diabetes patients by improving glycemic blood control.

Based on the company’s scientific excellence with a strong mission, Glucox Biotech aims to develop and produce the next generation safe and beneficial therapy for present and future diabetes suffers.

29 April 2010


Approval of patent in Europe

Glucox Biotech has been approved its third patent application in Europe in April 2010.

 

Read more

 

 

 

15 April 2010


Initiation of aminal studie case for novel compounds

Glucox Biotech has initiated a comprehensive animal study.

 

Read more